Fin Trust Capital Advisors, LLC Verrica Pharmaceuticals Inc. Transaction History
Fin Trust Capital Advisors, LLC
- $577 Million
- Q3 2024
A detailed history of Fin Trust Capital Advisors, LLC transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 10,000 shares of VRCA stock, worth $79,500. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$79,500% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding VRCA
# of Institutions
78Shares Held
14.2MCall Options Held
9.9KPut Options Held
6.5K-
Perceptive Advisors LLC New York, NY7.1MShares$56.4 Million1.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.29MShares$10.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.13MShares$8.98 Million0.0% of portfolio
-
State Street Corp Boston, MA513KShares$4.08 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA455KShares$3.62 Million0.0% of portfolio
About Verrica Pharmaceuticals Inc.
- Ticker VRCA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,094,100
- Market Cap $327M
- Description
- Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...